The seed round was led by PROfounders Capital to support product development and team expansion.
"We’re now seeing a huge rise in demand for preventative mental health solutions, especially as work from home isolation becomes the norm, and we’re drawing a lot of parallels with what happened in the digital fitness market. We’re excited to have the minds behind some of the biggest consumer and media businesses in the world helping us build the next big consumer brand in the mental health space. Our mission remains unchanged: we want to make the world a happier place by making looking after your mental health as normal as going to the gym."
The seed round was led by Atlantic Food Labs with participation from Seedcamp, MMC, and the Oxford Seed Fund.
"There’s never been a better time to build a digital health company, particularly in the diabetes space. With skyrocketing rates of chronic disease crippling our healthcare systems, the COVID-19 pandemic accelerating adoption of digital healthcare interventions, and increasing patient awareness of the importance of a healthy, balanced lifestyle, we’re not only hoping to build a massive business—but also to help millions of people across the world to live longer, happier lives."
The oversubscribed round was co-led by ADA Ventures and Slingshot Ventures to support the development of remote dental care technology.
"From first hand experience as dentists, we’ve seen patients have to overcome many hurdles in servicing their oral health needs. We are developing proprietary AI and Image Recognition technology to empower patients. With so many dental diseases preventable we are pioneering a new way for patients to uptake dental treatments and see a dentist on demand through amazing technology."
The funding round was led by Heal Capital and will support team expansion and product development.
"Healthcare touches each and every one of us and the recent pandemic has highlighted that at a global level. It showed the need to bring healthcare closer to people’s homes and that we need to leverage many of the recent innovations in digital health and consumer biotech to capture as many data points about human health as possible. This will transform our understanding of the human body and our approach to disease detection and management. At Sanome we are working toward developing multiple at home health tools to drive disruption within the healthcare landscape to benefit each one of us"
The Series B round was led by Lakestar with backing from institutional investors and venture funds to support team growth and product expansion.
"accuRx’s product has reinvigorated communication with our patients, enabling a better relationship between GPs and patients, which has ultimately led to better care provision. Our patients now have the confidence that they’re getting speedy and accurate responses from our team, and the use of regular Florey questionnaires to gather more information from our patients has been transformative for clinical record keeping and the care we provide. We’re thrilled that accuRx has received funding which will enable it to expand its primary care product set, some of which we’re trialling at the moment. We’re also excited about accuRx’s progress into secondary care as better interaction between primary and secondary care is a huge step forward for safer and more effective patient care."
